Some of the media outlets we have assisted…

OUR IMPACT
Our Vision
We seek to break the stigma and raise awareness around prescribed benzodiazepine injury, provide a voice to the patients who are suffering, and facilitate research and access to competent, evidence-based medical care for those impacted by benzodiazepine induced disability.
Recent Speaking and Events
Media Outreach
Selected media outreach. See more coverage, along with our podcast appearances, and media kit in our Press Room.





Our Programs
Ashton Manual Distribution Program
We adapted the Ashton Manual, one of the most important documents in the benzodiazepine literature, into several easy-to-share formats, including on our website, PDF, Amazon Kindle, and Barnes & Noble Nook. We share the manual worldwide for free. Through our efforts, the Ashton Manual is ranked the number one bestseller in both pharmacology and medication drug guides on Amazon. Get your copy here.
Benzodiazepine Action Work Group Colorado
We partnered with the Colorado Consortium to form the Benzodiazepine Action Work Group. Through this group, we develop programs and further awareness in Colorado.
Websites and Blog
Our website provides educational information to millions worldwide. We also maintain a blog filled with original educational content. With millions of hits, we’ve provided valuable information to patients, providers, and the public. Our blog can be found here.
Benzodiazepine Aware Provider List
As access to a provider knowledgeable about safer tapering is a common challenge patients face, we maintain a list of medical providers worldwide that may be helpful to patients hoping to slowly taper off their prescribed benzodiazepine.
FDA Reporting Program
We collaborate with patient groups to ensure benzodiazepine harm is reported. Our program grabbed the FDA’s attention, and they ultimately issued a boxed warning in 2020 after making their own inquiry. Learn more about the new warning here. We continue to encourage patients to report their harm. The instructions to file a report can be found here.
FDA Tapering Guidelines
Some of our organization’s members serve on a patient panel, informing the guidelines with our lived experience. We hope that the patient voice will be heard.
Informed Consent Initiative
We advocate for an accurate benzodiazepine informed consent process to be implemented at the time of prescription and cessation. See our Informed Consent for more information. Members of our organization have testified in legislative efforts to support informed consent. Some testimony is available on our YouTube channel.
Language Awareness Initiative
An initiative to correct inaccurate addiction terminology in the media and medical community.
Media Outreach and Professional Speaking
We speak about prescribed benzodiazepine harm and related topics in the media, including print, video, podcast, and in a professional capacity at various events and conferences. To see some of our work, visit our Press Room and Events. A playlist of some of our podcasts is available on Spotify.
Research and Publications
We are collaborating on several research projects, including a study on developing a toolkit for safely deprescribing benzos and a series of papers reporting results from a benzodiazepine patient experience survey. Our past research can be viewed on Research and Publications.
Safer Tapering Awareness Initiative
We developed our own literature regarding safe benzodiazepine deprescribing and speak regularly about the importance of safer cessation. See resources and our impact for more information.
Our Research and Publications


Long-term benzodiazepine receptor agonist (BZRA) use persists in healthcare settings worldwide and poses risks of patient harm. Objective
This study aimed to develop an intervention t…

















SAFE + EASY DONATIONS
Support Benzodiazepine Awareness and Help Us:
- Gain recognition of the existence and severity of prescribed benzodiazepine injury
- Hold and participate in events to educate prescribers and the public
- Push for policies that protect patients on benzodiazepines, whether they choose to remain on or taper off
- Protect those presented with benzodiazepines as a treatment option by giving them true informed consent
- Create more media awareness about this silent epidemic
- Advocate for more prescriber training in safe prescribing and cessation
- Fund research and show the need for future research that helps the harmed
